Serum uric acid and metabolic risk

Current Medical Research and Opinion

Volumn 29, Issue SUPPL.3, 2013, Pages 9-15

  Richette, P ^a   Perez Ruiz, F ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HOSPITAL DE CRUCES   (Spain)

Author keywords

Hyperuricemia; Metabolic risk; Type 2 diabetes; Uric acid

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; RETINOL BINDING PROTEIN 4; URIC ACID;

DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; HYPERTENSION; HYPERURICEMIA; INSULIN RESISTANCE; MEDLINE; METABOLIC SYNDROME X; NONHUMAN; REVIEW; RISK FACTOR; URIC ACID BLOOD LEVEL; WEIGHT GAIN;

ANIMALS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MODELS, ANIMAL; RISK FACTORS; URIC ACID;

EID: 84876930363     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2013.790801     Document Type: Review

References (58)

1. Oda M, Satta Y, Takenaka O, et al. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol 2002;19:640-53 (Pubitemid 34521296)
2. So A, Thorens B. Uric acid transport and disease. J Clin Invest 2010;120:1791-9
3. Choi HK, Ford ES, Li C, et al. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2007;57:109-15
4. Facchini F, Chen YD, Hollenbeck CB, et al. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 1991;266:3008-11
5. Dehghan A, Van Hoek M, Sijbrands EJG, et al. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 2008;31:361-2 (Pubitemid 351213351)
6. Chien KL, Chen MF, Hsu HC, et al. Plasma uric acid and the risk of type 2 diabetes in a Chinese community. Clin Chem 2008;54:310-16
7. Kodama S, Saito K, Yachi Y, et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care 2009;32:1737-42
8. Kramer CK, Von Mü hlen D, Jassal SK, et al. Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo Study. Diabetes Care 2009;32:1272-3
9. Ford ES, Li C, Cook S, et al. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 2007;115:2526-32 (Pubitemid 46763226)
10. Wang JY, Chen YL, Hsu CH, et al. Predictive value of serum uric acid levels for the diagnosis of metabolic syndrome in adolescents. J Pediatr 2012;161:753-6.e2
11. Cox CL, Stanhope KL, Schwarz JM, et al. Consumption of fructose-but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans. Nutr Metabol 2012;9:68-77
12. Nakagawa T, Hu H, Zharikov S, et al. A causal role for uric acid in fructoseinduced metabolic syndrome. Am J Physiol Renal Physiol 2006;290:F625-31 (Pubitemid 43724964)
13. Sanchez-Lozada LG, Tapia E, Bautista-Garcia P, et al. Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2008;294:F710-18
14. Reungjui S, Roncal CA, Mu W, et al. Thiazide diuretics exacerbate fructoseinduced metabolic syndrome. J Am Soc Nephrol 2007;18:2724-31 (Pubitemid 47531199)
15. Mazzali M, Hughes J, Kim YG, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001;38:1101-6 (Pubitemid 34252813)
16. Stavric B, Johnson WJ, Clayman S, et al. Effect of fructose administration on serum urate levels in the uricase inhibited rat. Experientia 1976;32:373-4
17. Johnson RJ, Segal MS, Sautin Y, et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 2007;86:899-906 (Pubitemid 47538288)
18. Doehner V, Schoene N, Rauchhaus M, et al. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebocontrolled studies. Circulation 2002;105:2619-24 (Pubitemid 34596038)
19. Coghlan JG, Flitter WD, Clutton SM, et al. Allopurinol pretreatment improves postoperative recovery and reduces lipid peroxidation in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 1994;107:248-56 (Pubitemid 24050525)
20. Kang DH, Park SK, Lee IK, et al. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005;16:3553-62
21. Khosla UM, Zharikov S, Finch JL, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005;67:1739-42 (Pubitemid 40577708)
22. Zoccali C, Maio R, Mallamaci F, et al. Uric acid and endothelial dysfunction in essential hypertension. J Am Soc Nephrol 2006;17:1466-71 (Pubitemid 43673429)
23. Farquharson CA, Butler R, Hill A, et al. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 2002;106:221-6 (Pubitemid 34761303)
24. Guthikonda S, Sinkey C, Barenz T, et al. Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers. Circulation 2003;107: 416-21 (Pubitemid 36158043)
25. Cook S, Hugli O, Egli M, et al. Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice. Swiss Med Wkly 2003;133:360-3 (Pubitemid 37064561)
26. Mercuro G, Vitale C, Cerquetani E, et al. Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol 2004;94:932-5 (Pubitemid 39349561)
27. Sautin YY, Nakagawa T, Zharikov S, et al. Adverse effects of the classical antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 2007;293:C584-96 (Pubitemid 47235197)
28. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752-61 (Pubitemid 40385531)
29. Cheung KJ, Tzameli I, Pissios P, et al. Xanthine oxidoreductase is a regulator of adipogenesis and PPARgamma activity. Cell Metab 2007;5:115-28 (Pubitemid 46187493)
30. Matsumoto S, Koshiishi I, Inoguchi T, et al. Confirmation of superoxide generation via xanthine oxidase in streptozotocin-induced diabetic mice. Free Radic Res 2003;37:767-72 (Pubitemid 36626436)
31. Takahashi S, Yamamoto T, Tsutsumi Z, et al. Close correlation between visceral fat accumulation and uric acid metabolism in healthy men. Metabolism 1997;46:1162-5 (Pubitemid 27418505)
32. Rathmann W, Funkhouser E, Dyer AR, et al. Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary Artery Risk Development in Young Adults. Ann Epidemiol 1998;8:250-61 (Pubitemid 28208943)
33. Choi HK, Atkinson K, Karlson EW, et al. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 2005;165:742-8 (Pubitemid 40569426)
34. Nakagawa T, Tuttle KR, Short RA, et al. Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol 2005;1:80-6
35. Johnson RJ, Perez-Pozo SE, Sautin YY, et al. Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev 2009;30:96-116
36. Masuo K, Kawaguchi H, Mikami H, et al. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003;42:474-80 (Pubitemid 37237341)
37. Niskanen L, Laaksonen DE, Lindstrom J, et al. Serum uric acid as a harbinger of metabolic outcome in subjects with impaired glucose tolerance: the Finnish Diabetes Prevention Study. Diabetes Care 2006;29:709-11 (Pubitemid 44115381)
38. Zhang Q, Zhang C, Song X, et al. A longitudinal cohort based association study between uric acid level and metabolic syndrome in Chinese Han urban male population. BMC Public Health 2012;12:419
39. Keenan T, Blaha MJ, Nasir K, et al. Relation of uric acid to serum levels of high-sensitivity C-reactive protein, triglycerides, and high-density lipoprotein cholesterol and to hepatic steatosis. Am J Cardiol 2012;110:1787-92
40. Viazzi F, Leoncini G, Vercelli M, et al. Serum uric acid levels predict new-onset type 2 diabetes in hospitalized patients with primary hypertension: the MAGIC study. Diabetes Care 2011;34:126-8
41. Bhole V, Choi JW, Kim SW, et al. Serum uric acid levels and the risk of type 2 diabetes: a prospective study. Am J Med 2010;123:957-61
42. Stanhope KL, Schwarz JM, Keim NL, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009;119:1322-34
43. Yamada J, Tomiyama H, Yambe M, et al. Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Atherosclerosis 2006;189:198-205 (Pubitemid 44441282)
44. Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356-62 (Pubitemid 41065039)
45. Santos RD. Elevated uric acid, the metabolic syndrome and cardiovascular disease: cause, consequence, or just a not so innocent bystander? Endocrine 2012;41:350-2
46. Klein BE, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 2002;25:1790-4 (Pubitemid 41071088)
47. Choi HK, Atkinson K, Karlson EW, et al. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004;350:1093-103 (Pubitemid 38298989)
48. Fung TT, Schulze M, Manson JE, et al. Dietary patterns, meat intake, and the risk of type 2 diabetes in women. Arch Intern Med 2004;164: 2235-40 (Pubitemid 39452984)
49. Schulze MB, Manson JE, Willett WC, et al. Processed meat intake and incidence of type 2 diabetes in younger and middle-aged women. Diabetologia 2003;46:1465-73 (Pubitemid 37518567)
50. Zhang C, Schulze MB, Solomon CG, Hu FB. A prospective study of dietary patterns, meat intake and the risk of gestational diabetes mellitus. Diabetologia 2006;49:2604-13
51. Song Y, Manson JE, Buring JE, Liu S. A prospective study of red meat consumption and type 2 diabetes in middle-aged and elderly women: the women's health study. Diabetes Care 2004;27:2108-15 (Pubitemid 39167171)
52. Choi HK, Curhan G. Coffee, tea, and caffeine consumption and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2007;57:816-21 (Pubitemid 46932088)
53. Campos H, Baylin A. Coffee consumption and risk of type 2 diabetes and heart disease. Nutr Rev 2007;65:173-9 (Pubitemid 351804374)
54. Liu S, Choi HK, Ford E, et al. A prospective study of dairy intake and the risk of type 2 diabetes in women. Diabetes Care 2006;29:1579-84 (Pubitemid 44127584)
55. Butler R, Morris AD, Belch JJ, et al. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 2000;35:746-51 (Pubitemid 30165320)
56. George J, Carr E, Davies J, et al. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 2006;114:2508-16 (Pubitemid 44901524)
57. Cirillo P, Gersch MS, Mu W, et al. Ketohexokinase-dependent proinflammatory effect of fructose in human proximal tubular cells. J Am Soc Nephrol 2009;20:545-53
58. Pacher P, Nivorozhkin A, Szabo C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev 2006;58:87-114